Debt to Equity Ratio Chart

View Debt to Equity Ratio for DYAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 -2.114
March 31, 2026 -12.39
December 31, 2025 4.106
September 30, 2025 1.942
June 30, 2025 -9.560
March 31, 2025 5.484
December 31, 2024 2.051
September 30, 2024 1.574
June 30, 2024 1.756
March 31, 2024 1.318
December 31, 2023 0.0233
September 30, 2023 0.0194
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
Date Value
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 -17.11
June 30, 2015 -3.786
March 31, 2015 -4.134
December 31, 2014 -3.814
September 30, 2014 -10.70
June 30, 2014 -83.68
March 31, 2014 6.072

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Agenus, Inc. -1.458
Amgen, Inc. 4.903
Anika Therapeutics, Inc. 0.1839
BioCryst Pharmaceuticals, Inc. -1.842
Imunon, Inc. 1.873